Filing Details
- Accession Number:
- 0001348362-25-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-30 12:37:08
- Reporting Period:
- 2025-07-29
- Filing Date:
- 2025-07-30
- Accepted Time:
- 2025-07-30 12:37:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348362 | Lexaria Bioscience Corp. | LEXX | Pharmaceutical Preparations (2834) | 202000871 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658613 | Edward William Mckechnie | 235 Westvale Drive Waterloo A6 N2T 1Y1 | Yes | No | No | No |
Transaction Summary
| Purchased: | 5,000 shares | Avg. Price: $0.91 | Total Value: $4,531.50 |
| Number of Shares After Transactions: | 18,191 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2025-07-29 | 5,000 | $0.91 | 18,191 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 13,191 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Options | $3.00 | 2021-04-26 | 2026-04-26 | 1,500 | 1,500 | Direct |
| Common Shares | Stock Options | $3.00 | 2021-06-08 | 2026-06-08 | 5,000 | 6,500 | Direct |
| Common Shares | Stock Options | $3.00 | 2021-09-01 | 2026-09-01 | 1,900 | 8,400 | Direct |
| Common Shares | Stock Options | $3.39 | 2022-03-08 | 2027-03-08 | 3,400 | 11,800 | Direct |
| Common Shares | Stock Options | $1.96 | 2022-10-12 | 2027-10-12 | 18,200 | 30,000 | Direct |
| Common Shares | Stock Options | $0.87 | 2023-07-25 | 2028-07-25 | 5,000 | 35,000 | Direct |
| Common Shares | Stock Options | $2.36 | 2024-04-26 | 2029-04-26 | 5,000 | 40,000 | Direct |
| Common Shares | Stock Options | $3.39 | 2024-07-26 | 2029-07-26 | 12,000 | 52,000 | Direct |
| Common Shares | Stock Options | $1.04 | 2025-05-15 | 2030-05-15 | 11,000 | 63,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-04-26 | 1,500 | 1,500 | Direct |
| 2026-06-08 | 5,000 | 6,500 | Direct |
| 2026-09-01 | 1,900 | 8,400 | Direct |
| 2027-03-08 | 3,400 | 11,800 | Direct |
| 2027-10-12 | 18,200 | 30,000 | Direct |
| 2028-07-25 | 5,000 | 35,000 | Direct |
| 2029-04-26 | 5,000 | 40,000 | Direct |
| 2029-07-26 | 12,000 | 52,000 | Direct |
| 2030-05-15 | 11,000 | 63,000 | Direct |
Billionaire Hedge Funds
